ELITECH CLINICAL SYSTEMS GLUCOSE PAP SL ELITECH CLINICAL SYSTEMS ELICAL 2, ELITECH CLINICAL SYSTEMS ELITROL 1 AND 2— 510(k) K100525

Substantially Equivalent

Seppim S.A.S.

FDA 510(k) clearance K100525 for ELITECH CLINICAL SYSTEMS GLUCOSE PAP SL ELITECH CLINICAL SYSTEMS ELICAL 2, ELITECH CLINICAL SYSTEMS ELITROL 1 AND 2, Substantially Equivalent on 2010-12-15. Applicant: Seppim S.A.S.. Device class: 2.

Clearance details

Applicant
Seppim S.A.S.
Product code
Code CGA
Device class
Class 2
Regulation
21 CFR 862.1345
Advisory panel
Clinical Chemistry
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Bothell, WA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code CGA

view all

More clearances from Seppim S.A.S.

view all

Adverse events under product code CGA

product code CGA
Death
2
Malfunction
1,816
Total
1,818

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recalls naming K100525

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K100525.

Data sourced from openFDA. This site is unofficial and independent of the FDA.